SDGR

Schrödinger, Inc. (SDGR) | Rumor.io

Schrödinger

SDGR

Attention (50-day avg)0%

Attention rank (50-day avg)#697

Bullish sentiment (50-day avg)90%

Price to earnings ratio44.4

Market capitalization2.2B

Earnings per share-0.74

Dividend yield (TTM)—

Revenue (annual)255.9M

Net income (annual)-103.3M

Social

What share of all stock conversation is about SDGR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.01	0.01% -0.01	0.01% +0	0% -0.01

Sep 23

$SDGR is experiencing heavy accumulation and is heavily shorted, which may prevent a pullback.
The company's product is gaining traction with large pharmaceutical companies, which could be a positive indicator for the company's future.
There is a possibility of a big crack coming for $SDGR, and the stock has already reached a high point, making it vulnerable to a sharp decline.

Generated by AI

Sentiment

Of the messages about SDGR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% 0	89.95% -4.74	87.99% -6.66	85.4% +8.91
Bearish	0% 0	10.05% +4.74	12.01% +6.66	14.6% -8.91

Bullish· Sep 17

The company is making significant progress in the development of new small molecule programs, which is driving investor interest and pushing the stock price up.
The announcement of Tectora, a new company formed by Schrödinger, has been well-received by investors, as it allows the company to keep upside exposure without funding the programs entirely on its own balance sheet.
The stock's momentum is building, with a 7-day return near 25% and a 90-day return above 50%, and longer-term holders are still recovering from significant losses over the past 5 years.

Bearish· Aug 3

The company's report was not great, which may negatively impact the stock.
The stock's high market cap relative to its revenue and cash is unsustainable and may lead to a decline.
The company's growth in software revenue and decline in drug discovery contribution due to timing issues on collaborations may not be enough to justify its current price.

Generated by AI

Topics

Of the messages about SDGR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	33.33%	50%	49.02%	64.36%
Technical Analysis	66.67%	50%	23.18%	17.94%
Macro	0%	0%	1.54%	5.24%
Analysts	0%	0%	26.26%	11.86%
Controversies	0%	0%	0%	0.18%
Earnings	0%	0%	0%	0.42%

Analysts· Feb 21

Schrödinger, Inc. (SDGR) discussion revolves around the concept of Schrödinger waves and their relation to higher-dimensional space.
The post highlights the analogy between waves in three-dimensional space and Schrödinger waves in the context of two-dimensional space.
The topic is relevant to analysts exploring the theoretical aspects of Schrödinger waves and their applications.

Announcements· Sep 19

SDGR is up 66% over the past 30 days, indicating a significant increase in stock value.
Schrödinger Inc. (SDGR) develops physics-based computational software for drug discovery and materials science.
The company's software helps accelerate the discovery process, potentially leading to breakthroughs in these fields.

Macro· Jul 6

SDGR has a strong 1Q22, with revenue growth of 43% YoY and a gross margin of 91%.
The company's AI-powered platform has seen increased adoption in the life sciences industry, with a focus on molecular dynamics and quantum mechanics.
SDGR's strong financial performance and growing customer base have led to a reiteration of a "buy" rating by analysts, with a 12-month price target of $140.

Generated by AI

Community

Of the messages about SDGR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	14.29%	5.75%	8.47%	9%
Newcomers	85.71%	94.25%	91.53%	91%

Regulars· Sep 18

The regulars are expecting a significant price drop, with some predicting a "crack" to $27 and others shorting at $30.
There are indications that the price may be due for a correction, with one regular noting that the stock can drop as quickly as it has risen in recent days.
Despite the recent run, the regulars are advising caution and patience, with one noting that the market needs time and that "Ruhe bewahren ist nicht immer einfach" (calmness is not always easy) after a significant rise.

Newcomers· Sep 20

The newcomer is considering revisiting Schrödinger, Inc. ($SDGR) due to the recent surge in AI biotech companies.
The stock's price has increased by 26% today with no apparent reason.
The newcomer is aware of the stock's past performance and is contemplating a potential investment.

Generated by AI

Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

14d agoYahoo Finance

Schrodinger Inc stock hits 52-week high at 23.06 USD

14d agoInvesting.com

Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates

Schrodinger (SDGR), along with New Enterprise Associates and RA Capital Management, established a ne

21d agoYahoo Finance

“Schrodinger’s Strait:” Why Hormuz Now Exists in a State of Permanent Uncertainty

Nobody agrees on how much oil is actually moving through the Strait of Hormuz right now, not the government, not the satellite trackers, and not the tanker CEOs navigating the chaos. That uncertainty is minting fortunes for some and shutting others out entirely.

26d agoYahoo Finance

Also Discussed

Investors talking about SDGR also mention

#	Name	Attention
1	EXAI - Exscientia plc	——
2	AbCellera Biologics Inc.ABCL	0.24%-0.06
3	10x Genomics Inc. Class A Common StockTXG	0%-0.02
4	Nayax Ltd.NYAX	0%0
5	PROCEPT BioRobotics Corp.PRCT	0%0
6	Recursion Pharmaceuticals, Inc. Class A Common StockRXRX	0.01%+0
7	Relay Therapeutics Inc.RLAY	0%new
8	MMMB - MamaMancini's Holdings, Inc.	——
9	Empire State Realty OP, L.P. Series 250 Operating Partnership UnitsFISK	0%0
10	MMX - Maverix Metals Inc.	——

Schrödinger, Inc.

Healthcare
Health Information Services

Schrödinger, Inc. is a life sciences software and biotechnology company that develops a physics-based computational platform for molecular discovery. The company provides software tools used to model and simulate chemical and biological systems, helping researchers identify and optimize novel molecules for drug discovery and materials science. Its platform is used across the pharmaceutical, biotechnology, materials, and industrial research sectors, supporting workflows such as molecular design, simulation, and collaboration. Schrödinger also operates a drug discovery segment that applies its technology to proprietary and partnered research programs. Headquartered in New York and founded in 1990, Schrödinger plays a specialized role in the market as a provider of advanced computational chemistry solutions for scientific innovation.

Website

Location

1540 Broadway

New York, NY, 10036

United States

Social

What share of all stock conversation is about SDGR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.01	0.01% -0.01	0.01% +0	0% -0.01

Sep 23

$SDGR is experiencing heavy accumulation and is heavily shorted, which may prevent a pullback.
The company's product is gaining traction with large pharmaceutical companies, which could be a positive indicator for the company's future.
There is a possibility of a big crack coming for $SDGR, and the stock has already reached a high point, making it vulnerable to a sharp decline.

Generated by AI

Sentiment

Of the messages about SDGR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% 0	89.95% -4.74	87.99% -6.66	85.4% +8.91
Bearish	0% 0	10.05% +4.74	12.01% +6.66	14.6% -8.91

Bullish· Sep 17

The company is making significant progress in the development of new small molecule programs, which is driving investor interest and pushing the stock price up.
The announcement of Tectora, a new company formed by Schrödinger, has been well-received by investors, as it allows the company to keep upside exposure without funding the programs entirely on its own balance sheet.
The stock's momentum is building, with a 7-day return near 25% and a 90-day return above 50%, and longer-term holders are still recovering from significant losses over the past 5 years.

Bearish· Aug 3

The company's report was not great, which may negatively impact the stock.
The stock's high market cap relative to its revenue and cash is unsustainable and may lead to a decline.
The company's growth in software revenue and decline in drug discovery contribution due to timing issues on collaborations may not be enough to justify its current price.

Generated by AI

Topics

Of the messages about SDGR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	33.33%	50%	49.02%	64.36%
Technical Analysis	66.67%	50%	23.18%	17.94%
Macro	0%	0%	1.54%	5.24%
Analysts	0%	0%	26.26%	11.86%
Controversies	0%	0%	0%	0.18%
Earnings	0%	0%	0%	0.42%

Analysts· Feb 21

Schrödinger, Inc. (SDGR) discussion revolves around the concept of Schrödinger waves and their relation to higher-dimensional space.
The post highlights the analogy between waves in three-dimensional space and Schrödinger waves in the context of two-dimensional space.
The topic is relevant to analysts exploring the theoretical aspects of Schrödinger waves and their applications.

Announcements· Sep 19

SDGR is up 66% over the past 30 days, indicating a significant increase in stock value.
Schrödinger Inc. (SDGR) develops physics-based computational software for drug discovery and materials science.
The company's software helps accelerate the discovery process, potentially leading to breakthroughs in these fields.

Macro· Jul 6

SDGR has a strong 1Q22, with revenue growth of 43% YoY and a gross margin of 91%.
The company's AI-powered platform has seen increased adoption in the life sciences industry, with a focus on molecular dynamics and quantum mechanics.
SDGR's strong financial performance and growing customer base have led to a reiteration of a "buy" rating by analysts, with a 12-month price target of $140.

Generated by AI

Community

Of the messages about SDGR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	14.29%	5.75%	8.47%	9%
Newcomers	85.71%	94.25%	91.53%	91%

Regulars· Sep 18

The regulars are expecting a significant price drop, with some predicting a "crack" to $27 and others shorting at $30.
There are indications that the price may be due for a correction, with one regular noting that the stock can drop as quickly as it has risen in recent days.
Despite the recent run, the regulars are advising caution and patience, with one noting that the market needs time and that "Ruhe bewahren ist nicht immer einfach" (calmness is not always easy) after a significant rise.

Newcomers· Sep 20

The newcomer is considering revisiting Schrödinger, Inc. ($SDGR) due to the recent surge in AI biotech companies.
The stock's price has increased by 26% today with no apparent reason.
The newcomer is aware of the stock's past performance and is contemplating a potential investment.

Generated by AI

Schrödinger

Social

Sep 23

Bullish· Sep 17

Bearish· Aug 3

Analysts· Feb 21

Announcements· Sep 19

Macro· Jul 6

Regulars· Sep 18

Newcomers· Sep 20

Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs

Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing

Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?

Schrodinger Inc stock hits 52-week high at 23.06 USD

Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates

“Schrodinger’s Strait:” Why Hormuz Now Exists in a State of Permanent Uncertainty

Also Discussed

Schrödinger, Inc.

Company Information

Location

Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs

Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing

Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?

Schrodinger Inc stock hits 52-week high at 23.06 USD

Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates

“Schrodinger’s Strait:” Why Hormuz Now Exists in a State of Permanent Uncertainty

Also Discussed

Social

Sep 23

Bullish· Sep 17

Bearish· Aug 3

Analysts· Feb 21

Announcements· Sep 19

Macro· Jul 6

Regulars· Sep 18

Newcomers· Sep 20